- Home
- KYMR vs VOYA Comparison
KYMR vs VOYA Comparison
Compare KYMR & VOYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KYMR | VOYA |
|---|---|---|
| Founded | 2015 | 1975 |
| Country | United States | United States |
| Employees | N/A | 11000 |
| Industry | Medicinal Chemicals and Botanical Products | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 7.4B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | KYMR | VOYA |
|---|---|---|
| Price | $76.20 | $88.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 26 | 10 |
| Target Price | ★ $107.72 | $84.90 |
| AVG Volume (30 Days) | 473.1K | ★ 1.0M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.31% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $39,211,000.00 | N/A |
| Revenue This Year | $10.61 | $3.13 |
| Revenue Next Year | $8.17 | $3.93 |
| P/E Ratio | ★ N/A | $12.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $36.88 | $64.50 |
| 52 Week High | $103.00 | $90.52 |
Technical Indicators
Market Signals| Indicator | KYMR | VOYA |
|---|---|---|
| Relative Strength Index (RSI) | 41.69 | 71.39 |
| Support Level | $73.31 | $72.94 |
| Resistance Level | $77.93 | N/A |
| Average True Range (ATR) | 3.06 | 1.99 |
| MACD | -0.46 | 0.46 |
| Stochastic Oscillator | 46.87 | 76.48 |
Price Performance
Historical ComparisonAbout KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.
About VOYA Voya Financial Inc.
Voya Financial Inc is a financial services company, which, through its subsidiaries, provides various investment, insurance, and retirement solutions to individual and institutional clients in the United States. Its products and services include tax savings plans, individual retirement accounts, group life insurance plans, and employee benefits products, among others. The company tailors each of its products to the needs of its customer base. It operates its business through three principal lines: Retirement, Investment Management and Employee Benefits.The majority revenue is from Retirement segment.